Cmg financial emblem dominating the new england skyline

CMG Financial Expands Presence in New England Through Strategic Acquisition of Shamrock Home Loans’ Origination Team

California-based mortgage lender strengthens its position with a strategic acquisition

In a strategic move aimed at enhancing its presence in New England, CMG Financial, a prominent California-based mortgage lender, has integrated Shamrock Home Loans’ origination team. This acquisition marks a significant milestone for CMG Financial as it continues to expand its operations and strengthen its position in the mortgage lending industry.

A Strategic Integration for Enhanced Market Presence

Under the leadership of Kurt Noyce, Chief Growth Officer, and Rod Correia, President, Shamrock Home Loans’ origination team will join CMG Financial. This team of sales and support professionals will remain in their current locations and be branded as Shamrock, Powered by CMG Home Loans. The integration of Shamrock’s expertise and resources will further enhance CMG Financial’s capabilities in serving the New England market.

CMG Financial’s Growth Strategy in Action

This integration is not the first strategic move by CMG Financial. Earlier this year, the company acquired Homebridge Financial Services’ retail division, expanding its retail lending business footprint. CMG Financial’s commitment to growth and innovation has positioned it as a leading mortgage lender in the country.

CMG Financial’s Impressive Standing in the Industry

According to estimates from Inside Mortgage Finance (IMF), CMG Financial ranked as the 16th-largest mortgage lender in the United States in the first nine months of 2023, with a total volume of $16 billion. This represents a significant increase of 17.5% compared to the previous year. With 1,826 loan officers and 401 active branches as of November 21, CMG Financial continues to establish itself as a major player in the industry.

The Success Story of Shamrock’s Origination Team

Shamrock’s origination team has achieved remarkable success, originating approximately $300 million in loans so far this year, according to data from the mortgage platform Modex. With eight loan officers and 13 branches, Shamrock has established itself as a trusted provider of mortgage services.

The Synergy Behind the Integration

Rod Correia, President of Shamrock Home Loans, highlighted CMG Financial’s diverse product portfolio as a key factor in their decision to join forces. CMG Financial offers a wide range of financing options, including construction-to-perm, renovation financing, builder programs, and home equity lines of credit. This expansive portfolio aligns with Shamrock’s commitment to providing comprehensive solutions to its clients.

A Strategic Move for Expansion and Growth

The integration of Shamrock Home Loans’ origination team with CMG Financial signifies a strategic move to expand CMG Financial’s presence in New England. With its impressive industry standing, commitment to growth, and innovative product offerings, CMG Financial is well-positioned to serve the evolving needs of borrowers in the region. As the mortgage industry continues to evolve, CMG Financial remains dedicated to providing exceptional service and empowering individuals on their homeownership journey.

Explore CMG Financial’s Range of Financing Options Today

Ready to Take the Next Step in Your Mortgage Journey?

To learn more about CMG Financial’s diverse product portfolio and begin your mortgage journey, visit our website.

Start Your Homeownership Journey with CMG Financial

Explore Financing Options

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Boom in Cancer: Game-Changer or Just Hype?

The promise of artificial intelligence (AI) in the field of oncology is nothing short of revolutionary. As the world grapples with the complexities of cancer, AI is emerging as a potential game-changer in diagnostics, treatment personalization, and drug discovery.

By |January 15, 2025|Categories: Article, Healthcare, Technology|Tags: |0 Comments

HHS Unveils AI Strategic Plan to Revolutionize Healthcare

The U.S. Department of Health and Human Services (HHS) has unveiled its ambitious AI Strategic Plan, a comprehensive blueprint aimed at revolutionizing healthcare, human services, and public health through the transformative power of artificial intelligence.

By |January 15, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

United States Naval Academy Class of 2024 Graduation

The ceremony was graced by the presence of three distinguished speakers, whose words of wisdom and encouragement left a lasting impression on the attendees.

By |January 14, 2025|Categories: Article, Education, Military|Tags: , |0 Comments

AI Certifications: The Key to Future-Proofing Your Career

In the fast-paced world of artificial intelligence (AI), staying current with the latest technological advancements is crucial for professionals aiming to excel in their careers. As businesses increasingly integrate AI into their operations, the demand for skilled AI experts is surging.

By |January 14, 2025|Categories: Article, Education, Technology|Tags: , |0 Comments

Telemedicine: A Digital Revolution in Healthcare Amid COVID-19

The year 2020 marked a significant turning point in the global healthcare landscape, as the COVID-19 pandemic accelerated the adoption of digital technologies such as telemedicine.

By |January 14, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Genomic Biomarkers Market Thrives with Personalized Medicine Boom

The genomic biomarkers market is witnessing a significant surge, driven by the burgeoning demand for personalized medicine. According to the latest report, the market is projected to grow to $14.09 billion by 2028, marking a compound annual growth rate (CAGR) of 17.4%. This approach not only optimizes treatment effectiveness but also minimizes side effects, making it a cornerstone of modern healthcare.